Karyotype-specific microRNA signature in chronic lymphocytic leukemia.
Chromosomal abnormalities, immunoglobulin heavy chain variable-region (IGHV) gene mutation status, and zeta-associated protein 70 (ZAP-70) expression levels have independent prognostic relevance in chronic lymphocytic leukemia (CLL); however, their concordance is variable. Because deregulation of microRNAs has been linked to disease initiation and progression in CLL, we studied the value of the microRNAs as a signature for CLL patients with specific chromosomal abnormalities. We identified 32 microRNAs able to discriminate the 11q deletion, 17p deletion, trisomy 12, 13q deletion, and normal karyotype cytogenetic subgroups. The expression values of 9 among the 32 microRNAs (miR-151-3p, miR-34a, miR-29c, miR-29b, miR-155, miR-148a, miR-146a, miR-146b5p, and miR-640) were correlated with gene expression data from the same samples to assess their biologic impact on CLL. In this study we also found that IGHV unmutated, high expression of ZAP-70 protein, and low expression of the miR-223, miR-29c, miR-29b, and miR-181 family were strongly associated with disease progression in CLL cases harboring 17p deletion, whereas in those harboring trisomy 12 only high expression of the miR-181a, among the analyzed parameters, suggested more aggressive disease. Thus, the use of the microRNA-based classifications may yield clinically useful biomarkers of tumor behavior in CLL.
Visone
Rosa
R
Department of Molecular Virology, Immunology, and Medical Genetics and Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA.
Rassenti
Laura Z
LZ
Veronese
Angelo
A
Taccioli
Cristian
C
Costinean
Stefan
S
Aguda
Baltazar D
BD
Volinia
Stefano
S
Ferracin
Manuela
M
Palatini
Jeff
J
Balatti
Veronica
V
Alder
Hansjuerg
H
Negrini
Massimo
M
Kipps
Thomas J
TJ
Croce
Carlo M
CM
D014408:Biomarkers, Tumor / Q000096:biosynthesis* / Q000235:genetics; D002872:Chromosome Deletion; D002877:Chromosomes, Human; D005260:Female; D015973:Gene Expression Regulation, Leukemic; D006801:Humans; D007135:Immunoglobulin Variable Region / Q000235:genetics / Q000378:metabolism; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000235:genetics / Q000378:metabolism*; D008297:Male; D035683:MicroRNAs / Q000096:biosynthesis* / Q000235:genetics; D012334:RNA, Neoplasm / Q000096:biosynthesis* / Q000235:genetics; D014314:Trisomy; D051746:ZAP-70 Protein-Tyrosine Kinase / Q000235:genetics / Q000378:metabolism
D014408:Biomarkers, Tumor; D007135:Immunoglobulin Variable Region; D035683:MicroRNAs; D012334:RNA, Neoplasm; D051746:ZAP-70 Protein-Tyrosine Kinase